Coronary artery disease is the number one cause of death in patients with chronic kidney disease (CKD). However,patients with impaired renal function are much less likely than patients with normal renal function to undergo left heart catheterization and coronary intervention. Patients that do receive invasive strategies experience more bleeding and higher rates of ischemic events. In this review, we examine advances in percutaneous coronary intervention--including antiplatelet therapy and drug-eluting stents--and their impact on patients with CKD.
|Original language||English (US)|
|Number of pages||5|
|Journal||Advances in peritoneal dialysis. Conference on Peritoneal Dialysis|
|State||Published - Dec 1 2010|
ASJC Scopus subject areas